MedPath

Effect of kumudadi lepa in darunaka (dandruff).

Phase 3
Conditions
Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Registration Number
CTRI/2023/04/051328
Lead Sponsor
All India Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Diagnosed patients of Darunaka grade 2 or more than that will be selected.

2.Patients who will be willing to participate in the trial.

3. patient of age group 20 - 60 years irrespective of cast, sex and religion.

Exclusion Criteria

1.Patients with other scalp disorders like psoriasis, Tinea capitis etc.

2. Patients suffering from severe acute illness.

3. Patients having any kind of fungal infection over scalp.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of effect of treatment will done in term of complete remission, marked <br/ ><br>improvement, mild improvement and unchanged will observe by adopting following <br/ ><br>criteria. <br/ ><br>Cured /Marked Improvement: - <br/ ><br>Patients showing more than 75% of relief in the sign and symptoms will consider as <br/ ><br>cured. <br/ ><br> <br/ ><br>44 <br/ ><br> <br/ ><br>Moderate Improvement: - <br/ ><br>Patients showing 51% to 75% of relief in the sign and symptoms will consider as <br/ ><br>moderately improved. <br/ ><br>Mild Improvement: - <br/ ><br>Patients showing 25% to 50% of relief in the sign and symptoms will consider as <br/ ><br>mildly improved. <br/ ><br>Unimproved: - Patients showing less than 25% of relief in the sign and symptoms <br/ ><br>will consider as unimproved.Timepoint: 30 days
Secondary Outcome Measures
NameTimeMethod
To improve the Quality of Life this will be assessed with the help of DLQI proforma and <br/ ><br>Disease specific Quality of Life proforma will be used if available.Timepoint: 30 days
© Copyright 2025. All Rights Reserved by MedPath